Roach DJ, et al. Clinical and genomic characterization of a cohort of patients with Klebsiella pneumoniae bloodstream infection. Clin Infect Dis. 2023.

Hassoun-Kheir N, et al. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe. Clin Microbiol Infect. 2023.

Leal J, et al. Development of a novel electronic surveillance system for monitoring of bloodstream infections. Infect Control Hosp Epidemiol. 2010;31(7):740–7.

Article  PubMed  Google Scholar 

Friedman ND, et al. Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–7.

Article  PubMed  Google Scholar 

Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

Article  CAS  PubMed  Google Scholar 

Quan H, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.

Article  PubMed  Google Scholar 

Stewart AG, Laupland KB, Tabah A. Central line associated and primary bloodstream infections. Curr Opin Crit Care. 2023;29(5):423–9.

Article  PubMed  Google Scholar 

Bell JM et al. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2022. Commun Dis Intell (2018). 2023;47.

Girometti N, et al. Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy. Med (Baltim). 2014;93(17):298–309.

Article  CAS  Google Scholar 

De Oliveira DMP et al. Antimicrobial Resistance in ESKAPE Pathogens. Clin Microbiol Rev, 2020. 33(3).

Siu LK, et al. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12(11):881–7.

Article  PubMed  Google Scholar 

Meatherall BL, et al. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med. 2009;122(9):866–73.

Article  PubMed  Google Scholar 

Al-Hasan MN, et al. Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study. Mayo Clin Proc. 2010;85(2):139–44.

Article  PubMed  PubMed Central  Google Scholar 

Kao CY, et al. A 24-year longitudinal study of Klebsiella pneumoniae isolated from patients with bacteraemia and urinary tract infections reveals the association between capsular serotypes, antibiotic resistance, and virulence gene distribution. Epidemiol Infect. 2023;151:e155.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hafiz TA, et al. Klebsiella pneumoniae bacteraemia epidemiology: resistance profiles and clinical outcome of King Fahad Medical City isolates, Riyadh, Saudi Arabia. BMC Infect Dis. 2023;23(1):579.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song F, et al. Clinical characteristics, risk factors, and outcomes of patients with polymicrobial Klebsiella pneumoniae bloodstream infections. Biomed Res Int. 2021;2021:p6619911.

Article  Google Scholar 

Denisuik AJ, et al. Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016. J Antimicrob Chemother. 2019;74(Suppl 4):iv64–71.

Article  CAS  PubMed  Google Scholar 

Fils PEL, et al. ESBL-producing Klebsiella pneumoniae in a University hospital: molecular features, diffusion of epidemic clones and evaluation of cross-transmission. PLoS ONE. 2021;16(3):e0247875.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siriphap A, et al. High prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates: a 5-year retrospective study at a Tertiary Hospital in Northern Thailand. Front Cell Infect Microbiol. 2022;12:955774.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Richelsen R, et al. Risk factors of community-onset extended-spectrum β-lactamase Escherichia coli and Klebsiella pneumoniae bacteraemia: an 11-year population-based case-control-control study in Denmark. Clin Microbiol Infect. 2021;27(6):871–7.

Article  CAS  PubMed  Google Scholar 

John P, et al. Risk for primary cephalosporin resistance in Gram-negative bacteremia. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e121.

Article  PubMed  PubMed Central  Google Scholar 

Vance MK et al. Risk factors for bloodstream infections due to ESBL-producing Escherichia coli, Klebsiella spp., and Proteus mirabilis. Pharm (Basel). 2023;11(2).

Ling W, et al. Population-based incidence and characteristics of adult Escherichia coli bloodstream infection in Queensland, Australia, From 2000 to 2019. Open Forum Infect Dis. 2023;10(3):ofad071.

Article  PubMed  PubMed Central  Google Scholar 

Sawatwong P, et al. High burden of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in older adults: a seven-year study in two rural Thai Provinces. Am J Trop Med Hyg. 2019;100(4):943–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sammarro M, et al. Risk factors, temporal dependence, and seasonality of human extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae colonization in Malawi: a longitudinal model-based approach. Clin Infect Dis. 2023;77(1):1–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su C, et al. Prediction of 30-day mortality using the quick pitt bacteremia score in hospitalized patients with Klebsiella pneumoniae infection [Response to Letter]. Infect Drug Resist. 2023;16:5549–50.

Article  PubMed  PubMed Central  Google Scholar 

Li D, et al. Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2023;13:1157010.

Article  PubMed  PubMed Central  Google Scholar 

Hou W, et al. Is early time to positivity of blood culture associated with clinical prognosis in patients with Klebsiella pneumoniae bloodstream infection? Epidemiol Infect. 2023;151:e43.

Article  PubMed  PubMed Central  Google Scholar 

Chen J, et al. Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection. BMC Pulm Med. 2023;23(1):102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev. 2014;27(4):647–64.

Article  PubMed  PubMed Central  Google Scholar